Nanoparticles modulate surfactant protein A and D mediated protection against influenza A infection in vitro

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 370, Issue 1661, 2015, Pages

  McKenzie, Zofi ^a   Kendall, Michaela ^a,b   Mackay, Rose Marie ^a   Tetley, Teresa D ^c   Morgan, Cliff ^d   Griffiths, Mark ^d   Clark, Howard W ^a,e   Madsen, Jens ^a,e  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e University of Southampton   (United Kingdom)

Author keywords

Collectin; Innate immunity; Mucosal; Nanoparticles; Surface chemistry; Surfactant

Indexed keywords

CONCENTRATION (COMPOSITION); GERM CELL; IMMUNE RESPONSE; INFECTIOUS DISEASE; INFLUENZA; NANOTECHNOLOGY; PROTEIN;

NANOPARTICLE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

GENETICS; HUMAN; INFLUENZA A VIRUS; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; HUMANS; INFLUENZA A VIRUS; NANOPARTICLES; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D;

EID: 84919740946     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2014.0049     Document Type: Article

References (61)

1. Dockery DW, Pope CA, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG, Speizer FE. 1993 An association between air-pollution and mortality in 6 United-States cities. N. Engl. J. Med. 329, 1753–1759. (doi:10.1056/NEJM199312093292401)
2. Krewski D, Burnett R, Jerrett M, Pope CA, Rainham D, Calle E, Thurston G, Thun M. 2005 Mortality and long-term exposure to ambient air pollution: ongoing analyses based on the American Cancer Society cohort. J. Toxicol. Environ. Health Part A Curr. Issues 68, 1093–1109. (doi:10.1080/15287390590935941)
3. Lin YJ, Karuppiah M, Shaw A, Gupta G. 1999 Effect of simulated sunlight on atrazine and metolachlor toxicity of surface waters. Ecotoxicol. Environ. Saf. 43, 35–37. (doi:10.1006/eesa.1998.1751)
4. Kashima S, Yorifuji T, Tsuda T, Ibrahim J. 2010 Effects of traffic-related outdoor air pollution on respiratory illness and mortality in children, taking into account indoor air pollution, in Indonesia. J. Occup. Environ. Med. 52, 340–345. (doi:10.1097/JOM.0b013e3181d44e3f)
5. Stern G, Latzin P, Fuchs O, Proietti E, Kuehni C, Frey U. 2013 A prospective study of the impact of air pollution on respiratory symptoms and infections in infants. Am. J. Respir. Crit. Care Med. 187, 1341–1348. (doi:10.1164/rccm.201211-2008OC)
6. Dominici F, Peng RD, Bell ML, Pham L, McDermott A, Zeger SL, Samet JM. 2006 Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. J. Am. Med. Assoc. 295, 1127–1134. (doi:10.1001/jama.295.10.1127)
7. Jimenez E, Linares C, Martnez D. 2011 Particulate air pollution and short-term mortality due to specific causes among the elderly in Madrid (Spain): seasonal differences. Int. J. Environ. Health Res. 21, 372–390. (doi:10.1080/09603123.2011.560251)
8. Jedrychowski WA et al. 2013 Intrauterine exposure to fine particulate matter as a risk factor for increased susceptibility to acute broncho-pulmonary infections in early childhood. Int. J. Hyg. Environ. Health 216, 395–401. (doi:10.1016/j.ijheh.2012.12.014)
9. Gurley ES et al. 2013 Seasonal concentrations and determinants of indoor particulate matter in a low-income community in Dhaka, Bangladesh. Environ. Res. 121, 11–16.
10. Black RE, Morris SS, Bryce J. 2003 Where and why are 10 million children dying every year? Lancet 361, 2226–2234. (doi:10.1016/S0140-6736(03)13779-8)
11. Ciencewicki J, Gowdy K, Krantz QT, Linak WP, Brighton L, Gilmour MI, Jaspers I. 2007 Diesel exhaust enhanced susceptibility to influenza infection is associated with decreased surfactant protein expression. Inhal. Toxicol. 19, 1121–1133. (doi:10.1080/08958370701665426)
12. Gowdy KM, Krantz QT, King C, Boykin E, Jaspers I, Linak WP, Gilmour MI. 2010 Role of oxidative stress on diesel-enhanced influenza infection in mice. Part. Fibre Toxicol. 7, 34. (doi:10.1186/1743-8977-7-34)
13. Jaspers I et al. 2004 Diesel exhaust particles enhance influenza virus infections via oxidative stress. Free Radic. Biol. Med. 37, S142.
14. Jaspers I, Sheridan PA, Zhang W, Brighton LE, Chason KD, Hua X, Tilley SL. 2009 Exacerbation of allergic inflammation in mice exposed to diesel exhaust particles prior to viral infection. Part. Fibre Toxicol. 6, 22. (doi:10.1186/1743-8977-6-22)
15. Harrod KS, Jaramillo RJ, Rosenberger CL, Wang S-Z, Berger JA, McDonald JD, Reed MD. 2003 Increased susceptibility to RSV infection by exposure to inhaled diesel engine emissions. Am. J. Respir. Cell Mol. Biol. 28, 451–463. (doi:10.1165/rcmb.2002-0100OC)
16. Hahon N, Booth JA, Green F, Lewis TR. 1985 Influenza virus infection in mice after exposure to coal dust and diesel engine emissions. Environ. Res. 37, 44–60. (doi:10.1016/0013-9351(85)90048-9)
17. Crouch E, Hartshorn K, Horlacher T, McDonald B, Smith K, Cafarella T, Seaton B, Seeberger PH, Head J. 2009 Recognition of mannosylated ligands and influenza A virus by human surfactant protein D: contributions of an extended site and residue 343. Biochemistry 48, 3335–3345. (doi:10.1021/bi8022703)
18. Crouch E, Hartshorn K, Ofek I. 2000 Collectins and pulmonary innate immunity. Immunol. Rev. 173, 52–65. (doi:10.1034/j.1600-065X.2000.917311.x)
19. Hartshorn KL. 2010 Role of surfactant protein A and D (SP-A and SP-D) in human antiviral host defense. Front. Biosci. 2, 527–546. (doi:10.2741/s83)
20. Hartshorn KL, Webby R, White MR, Tecle T, Pan C, Boucher S, Moreland RJ, Crouch EC, Scheule RK. 2008 Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D. Respir. Res. 9, 65. (doi:10.1186/1465-9921-9-65)
21. Benne CA, Kraaijeveld CA, van Strijp JAG, Brouwer E, Harmsen M, Verhoef J, van Golde LMG, van Iwaarden JF. 1995 Interactions of surfactant protein-A with influenza-A viruses: binding and neutralization. J. Infect. Dis. 171, 335–341. (doi:10.1093/infdis/171.2.335)
22. van Eijk M, White MR, Batenburg JJ, Vaandrager AB, van Golde LMG, Haagsman HP, Hartshorn KL. 2004 Interactions of influenza A virus with sialic acids present on porcine surfactant protein D. Am. J. Respir. Cell Mol. Biol. 30, 871–879. (doi:10.1165/rcmb.2003-0355OC)
23. Tecle T, White MR, Crouch EC, Hartshorn KL. 2007 Inhibition of influenza viral neuraminidase activity by collectins. Arch. Virol. 152, 1731–1742. (doi:10.1007/s00705-007-0983-4)
24. Hartshorn KL, White MR, Voelker DR, Coburn J, Zaner K, Crouch EC. 2000 Mechanism of binding ofsurfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity. Biochem. J. 351, 449–458. (doi:10.1042/0264-6021:3510449)
25. White M, Kingma P, Tecle T, Kacak N, Linders B, Heuser J, Crouch E, Hartshorn K. 2008 Multimerization of surfactant protein D, but not its collagen domain, is required for antiviral and opsonic activities related to influenza virus. J. Immunol. 181, 7936–7943. (doi:10.4049/jimmunol.181.11.7936)
26. White MR, Crouch E, Chang D, Hartshorn KL. 2001 Increased antiviral and opsonic activity of a highly multimerized collectin chimera. Biochem. Biophys. Res. Commun. 286, 206–213. (doi:10.1006/bbrc.2001.5373)
27. Benne CA, Benaissa-Trouw B, Van Strijp JAG, Kraaijeveld CA, Van Iwaarden JFF. 1997 Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages. Eur. J. Immunol. 27, 886–890. (doi:10.1002/eji.1830270413)
28. Ruge CA, Kirch J, Schneider M, Perez-Gil J, Schaefer UF, Casals C, Lehr C-M. 2011 Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A. Nanomedicine 7, 690–693. (doi:10.1016/j.nano.2011.07.009)
29. Ruge CA et al. 2012 The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles. PLoS ONE 7, e40775. (doi:10.1371/journal.pone.0040775)
30. Kendall M, Ding P, Mackay R-M, Deb R, McKenzie Z, Kendall K, Madsen J, Clark H. 2013 Surfactant protein D (SP-D) alters cellular uptake of particles and nanoparticles. Nanotoxicology 7, 963–973. (doi:10.3109/17435390.2012.689880)
31. Schulze C, Schaefer UF, Ruge CA, Wohlleben W, Lehr C-M. 2011 Interaction of metal oxide nanoparticles with lung surfactant protein A. Eur. J. Pharm. Biopharm. 77, 376–383. (doi:10.1016/j.ejpb.2010.10.013)
32. Kendall M, Brown L, Trought K. 2004 Molecular adsorption at particle surfaces: a PM toxicity mediation mechanism. Inhal. Toxicol. 16, 99–105. (doi:10.1080/08958370490443187)
33. Wright JR et al. 1987 Surfactant apoprotein Mr ¼ 26,000–36,000 enhances uptake of liposomes by type II cells. J. Biol. Chem. 262, 2888–2894.
34. Strong P, Kishore U, Morgan C, Bernal AL, Singh M, Reid KBM. 1998 A novel method of purifying lung surfactant proteins A and D from the lung lavage of alveolar proteinosis patients and from pooled amniotic fluid. J. Immunol. Methods 220, 139–149. (doi:10.1016/S0022-1759(98)00160-4)
35. Hartshorn KL et al. 1988 Effects of influenza-A virus on human neutrophil calcium-metabolism. J. Immunol. 141, 1295–1301.
36. Kemp SJ, Thorley AJ, Gorelik J, Seckl MJ, O’Hare MJ, Arcaro A, Korchev Y, Goldstraw P, Tetley TD. 2008 Immortalization of human alveolar epithelial cells to investigate nanoparticle uptake. Am. J. Res. Cell Mol. Biol. 39, 591–597. (doi:10.1165/rcmb.2007-0334OC)
37. McKenzie Z et al. In press. Surfactant protein A (SPA) inhibits aggregation of toxic amine-modified nanoparticles and uptake into alveolar macrophages. Nanotoxicology.
38. Stone KC, Mercer RR, Gehr P, Stockstill B, Crapo JD. 1992 Allometric relationships of cell numbers and size in the mammalian lung. Am. J. Respir. Cell Mol. Biol. 6, 235–243. (doi:10.1165/ajrcmb/6.2.235)
39. Dobbs LG. 1990 Isolation and culture of alveolar type-II cells. Am. J. Physiol. 258, L134–L147.
40. Giard DJ et al. 1973 In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl Cancer Inst. 51, 1417–1423.
41. Foster KA et al. 1998 Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp. Cell Res. 243, 359–366. (doi:10.1006/excr.1998.4172)
42. Shapiro DL, Nardone LL, Rooney SA, Motoyama EK, Munoz JL. 1978 Phospholipid biosynthesis and secretion by a cell line (A549) which resembles type II aleveolar epithelial cells. Biochim. Biophys. Acta 530, 197–207. (doi:10.1016/0005-2760(78)90005-X)
43. Swain RJ, Kemp SJ, Goldstraw P, Tetley TD, Stevens MM. 2010 Assessment of cell line models of primary human cells by Raman spectral phenotyping. Biophys. J. 98, 1703–1711. (doi:10.1016/j.bpj.2009.12.4289)
44. Mason RJ, Williams MC. 1980 Phospholipid composition and ultrastructure of A549 cells and other cultured pulmonary epithelial cells of presumed type II cell origin. Biochim. Biophys. Acta 617, 36–50. (doi:10.1016/0005-2760(80)90222-2)
45. Gonzalez L et al. 2013 Co-assessment of cell cycle and micronucleus frequencies demonstrates the influence of serum on the in vitro genotoxic response to amorphous monodisperse silica nanoparticles of varying sizes. Nanotoxicology 8, 876–884. (doi:10.3109/17435390.2013.842266)
46. Grabowski N et al. 2013 Toxicity of surface-modified PLGA nanoparticles toward lung alveolar epithelial cells. Int. J. Pharm. 454, 686–694. (doi:10.1016/j.ijpharm.2013.05.025)
47. Okoturo-Evans O, Dybowska A, Valsami-Jones E, Cupitt J, Gierula M, Boobis AR, Edwards RJ. 2013 Elucidation of toxicity pathways in lung epithelial cells induced by silicon dioxide nanoparticles. PLoS ONE 8, e72363. (doi:10.1371/journal.pone.0072363)
48. Paranjpe M et al. 2013 In vitro and ex vivo toxicological testing of sildenafil-loaded solid lipid nanoparticles. Inhal. Toxicol. 25, 536–543. (doi:10.3109/08958378.2013.810315)
49. Wu H, Zhu H, Li X, Liu Z, Zheng W, Chen T, Yu B, Wong KH. 2013 Induction of apoptosis and cell cycle arrest in A549 human lung adenocarcinoma cells by surface encapping selenium nanoparticles: an effect enhanced by polysaccharides-protein complexes from Polyporus rhinocerus. J. Agric. Food Chem 61, 9859–9866. (doi:10.1021/jf403564s)
50. Tellabati A, Fernandes VE, Teichert F, Singh R, Rylance J, Gordon S, Andrew PW, Grigg J. 2010 Acute exposure of mice to high-dose ultrafine carbon black decreases susceptibility to pneumococcal pneumonia. Part. Fibre Toxicol. 7, 30. (doi:10.1186/1743-8977-7-30)
51. Xia T, Kovochich M, Liong M, Zink JI, Nel AE. 2008 Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. ACS Nano 2, 85–96. (doi:10.1021/nn700256c)
52. Whittaker G, Bui M, Helenius A. 1996 The role of nuclear import and export in influenza virus infection. Trends Cell Biol. 6, 67–71. (doi:10.1016/0962-8924(96)81017-8)
53. Martin K, Helenius A. 1991 Transport of incoming influenza-virus nucleocapsids into the nucleus. J. Virol. 65, 232–244.
54. Ruenraroengsak P, Novak P, Berhanu D, Thorley AJ, Valsami-Jones E, Gorelik J, Korchev YE, Tetley TD. 2012 Respiratory epithelial cytotoxicity and membrane damage (holes) caused by amine-modified nanoparticles. Nanotoxicology 6, 94–108. (doi:10.3109/17435390.2011.558643)
55. Miragoli M, Novak P, Ruenraroengsak P, Shevchuk AI, Korchev YE, Lab MJ, Tetley TD, Gorelik J. 2013 Functional interaction between charged nanoparticles and cardiac tissue: a new paradigm for cardiac arrhythmia? Nanomedicine 8, 725–737. (doi:10.2217/nnm.12.125)
56. He C, Hu Y, Yin L, Tang C, Yin C. 2010 Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31, 3657–3666. (doi:10.1016/j.biomaterials.2010.01.065)
57. Vijayakumar S, Ganesan S. 2012 Gold nanoparticles as an HIV entry inhibitor. Curr. HIV Res. 10, 643–646. (doi:10.2174/157016212803901383)
58. Frohlich E, Meindl C, Roblegg E, Griesbacher A, Pieber TR. 2012 Cytotoxity of nanoparticles is influenced by size, proliferation and embryonic origin of the cells used for testing. Nanotoxicology 6, 424–439. (doi:10.3109/17435390.2011.586478)
59. Roblegg E, Meindl C, Teubl B, Zaversky M, Zimmer A. 2012 Evaluation of a physiological in vitro system to study the transport of nanoparticles through the buccal mucosa. Nanotoxicology 6, 399–413. (doi:10.3109/17435390.2011.580863)
60. Wang XZ, Yang Y, Li R, McGuinnes C, Adamson J, Megson IL, Donaldson K. 2014 Principal component and causal analysis of structural and acute in vitro toxicity data for nanoparticles. Nanotoxicology 8, 465–476. (doi:10.3109/17435390.2013.796534)
61. Bexiga MG, Varela JA, Wang F, Fenaroli F, Salvati A, Lynch I, Simpson JC, Dawson KA. 2011 Cationic nanoparticles induce caspase 3-, 7- and 9-mediated cytotoxicity in a human astrocytoma cell line. Nanotoxicology 5, 557–567. (doi:10.3109/17435390.2010.539713)